Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al

Ann Rheum Dis. 2014 Jan;73(1):e5. doi: 10.1136/annrheumdis-2013-204617. Epub 2013 Oct 23.

Authors

Kazuki Yoshida¹, Yoon-Kyoung Sung, Arthur Kavanaugh, Sang-Cheol Bae, Michael E Weinblatt, Mitsumasa Kishimoto, Kazuo Matsui, Shigeto Tohma, Daniel H Solomon

Affiliation

¹ Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, , Boston, Massachusetts, USA.

PMID: 24152418
DOI: 10.1136/annrheumdis-2013-204617

No abstract available

Keywords: Adult Onset Still's Disease; Amyloidosis; Analgesics.

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents / administration & dosage*
Arthritis, Rheumatoid / drug therapy*
Biological Products / administration & dosage*
Humans
Withholding Treatment*

Substances

Antirheumatic Agents
Biological Products